
Windham Venture Partners
Description
Windham Venture Partners, established in 2006 and based in New York City, is a dedicated venture capital firm with a clear focus on the healthcare sector. The firm targets early to growth-stage companies that are poised to disrupt or significantly improve various facets of healthcare delivery and management. Their investment scope is broad within healthcare, encompassing innovative digital health solutions, advanced medical devices, precise diagnostics, and tech-enabled services designed to enhance efficiency and patient outcomes. Windham seeks out companies that not only possess groundbreaking technology but also demonstrate strong market potential and are led by experienced and visionary management teams.
The firm's investment philosophy centers on identifying and nurturing companies that can drive meaningful change in the healthcare landscape. They are known for their hands-on approach, actively partnering with their portfolio companies to provide strategic guidance, operational support, and access to their extensive network of industry experts and healthcare stakeholders. This collaborative model aims to accelerate growth, navigate complex regulatory environments, and facilitate market adoption for their portfolio companies, ultimately contributing to their long-term success and impact.
Windham Venture Partners typically deploys initial investments ranging from $2 million to $10 million, reflecting their commitment to supporting companies through critical early and growth phases. This capital is often complemented by follow-on investments as companies achieve key milestones and demonstrate further potential. The firm has successfully raised multiple funds, underscoring its consistent presence and capacity in the healthcare venture ecosystem. For instance, their Windham Venture Partners IV fund closed at $161 million in 2021, following their Windham Venture Partners III fund which closed at $100 million in 2017, demonstrating a strong track record of capital deployment and investor confidence.
Windham's deep specialization in healthcare, combined with its strategic investment approach and substantial capital base, positions it as a significant partner for entrepreneurs aiming to innovate within this vital industry. Their long-standing presence since 2006 and their focus on high-impact solutions make them a notable player in the healthcare venture capital landscape.
Investor Profile
Windham Venture Partners has backed more than 57 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 11% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 1 rounds in the past year.
- Typical check size: $2M – $10M.
Stage Focus
- Series B (33%)
- Series Unknown (19%)
- Series C (16%)
- Series A (12%)
- Series D (9%)
- Series E (4%)
- Debt Financing (2%)
- Seed (2%)
- Convertible Note (2%)
- Series G (2%)
Country Focus
- United States (98%)
- Israel (2%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Health Diagnostics
- Wellness
- Artificial Intelligence (Ai)
- Mhealth
- Information Technology
- Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.